Literature DB >> 15388427

AcrAB-TolC directs efflux-mediated multidrug resistance in Salmonella enterica serovar typhimurium DT104.

Sylvie Baucheron1, Shaun Tyler, David Boyd, Michael R Mulvey, Elisabeth Chaslus-Dancla, Axel Cloeckaert.   

Abstract

Multidrug-resistant Salmonella enterica serovar Typhimurium definitive phage type 104 (DT104) strains harbor a genomic island, called Salmonella genomic island 1 (SGI1), which contains an antibiotic resistance gene cluster conferring resistance to ampicillin, chloramphenicol, florfenicol, streptomycin, sulfonamides, and tetracyclines. They may be additionally resistant to quinolones. Among the antibiotic resistance genes there are two, i.e., floR and tet(G), which code for efflux pumps of the major facilitator superfamily with 12 transmembrane segments that confer resistance to chloramphenicol-florfenicol and the tetracyclines, respectively. In the present study we determined, by constructing acrB and tolC mutants, the role of the AcrAB-TolC multidrug efflux system in the multidrug resistance of several DT104 strains displaying additional quinolone resistance or not displaying quinolone resistance. This study shows that the quinolone resistance and the decreased fluoroquinolone susceptibilities of the strains are highly dependent on the AcrAB-TolC efflux system and that single mutations in the quinolone resistance-determining region of gyrA are of little relevance in mediating this resistance. Overproduction of the AcrAB efflux pump, as determined by Western blotting with an anti-AcrA polyclonal antibody, appeared to be the major mechanism of resistance to quinolones. Moreover, chloramphenicol-florfenicol and tetracycline resistance also appeared to be highly dependent on the presence of AcrAB-TolC, since the introduction of mutations in the respective acrB and tolC genes resulted in a susceptible or intermediate resistance phenotype, according to clinical MIC breakpoints, despite the presence of the FloR and Tet(G) efflux pumps. Resistance to other antibiotics, ampicillin, streptomycin, and sulfonamides, was not affected in the acrB and tolC mutants of DT104 strains harboring SGI1. Therefore, AcrAB-TolC appears to direct efflux-mediated resistance to quinolones, chloramphenicol-florfenicol, and tetracyclines in multidrug-resistant S. enterica serovar Typhimurium DT104 strains.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15388427      PMCID: PMC521921          DOI: 10.1128/AAC.48.10.3729-3735.2004

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  45 in total

1.  Interplay between efflux pumps may provide either additive or multiplicative effects on drug resistance.

Authors:  A Lee; W Mao; M S Warren; A Mistry; K Hoshino; R Okumura; H Ishida; O Lomovskaya
Journal:  J Bacteriol       Date:  2000-06       Impact factor: 3.490

2.  Gene replacement in gram-negative bacteria: the pMAKSAC vectors.

Authors:  D Favre; J F Viret
Journal:  Biotechniques       Date:  2000-02       Impact factor: 1.993

3.  Crystal structure of the bacterial membrane protein TolC central to multidrug efflux and protein export.

Authors:  V Koronakis; A Sharff; E Koronakis; B Luisi; C Hughes
Journal:  Nature       Date:  2000-06-22       Impact factor: 49.962

4.  Fluoroquinolone resistance in Salmonella: a web discussion.

Authors:  R Carnevale; K Molbak; F Bager; F M Aarestrup
Journal:  Clin Infect Dis       Date:  2000-07-26       Impact factor: 9.079

5.  One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products.

Authors:  K A Datsenko; B L Wanner
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

6.  Evidence for active efflux as the primary mechanism of resistance to ciprofloxacin in Salmonella enterica serovar typhimurium.

Authors:  E Giraud; A Cloeckaert; D Kerboeuf; E Chaslus-Dancla
Journal:  Antimicrob Agents Chemother       Date:  2000-05       Impact factor: 5.191

7.  An outbreak of multidrug-resistant, quinolone-resistant Salmonella enterica serotype typhimurium DT104.

Authors:  K Mølbak; D L Baggesen; F M Aarestrup; J M Ebbesen; J Engberg; K Frydendahl; P Gerner-Smidt; A M Petersen; H C Wegener
Journal:  N Engl J Med       Date:  1999-11-04       Impact factor: 91.245

8.  Multiresistant Salmonella Typhimurium DT104 infections of humans and domestic animals in the Pacific Northwest of the United States.

Authors:  T E Besser; M Goldoft; L C Pritchett; R Khakhria; D D Hancock; D H Rice; J M Gay; W Johnson; C C Gay
Journal:  Epidemiol Infect       Date:  2000-04       Impact factor: 2.451

9.  Ineffectiveness of topoisomerase mutations in mediating clinically significant fluoroquinolone resistance in Escherichia coli in the absence of the AcrAB efflux pump.

Authors:  M Oethinger; W V Kern; A S Jellen-Ritter; L M McMurry; S B Levy
Journal:  Antimicrob Agents Chemother       Date:  2000-01       Impact factor: 5.191

10.  Changes in antimicrobial resistance among Salmonella enterica Serovar typhimurium isolates from humans and cattle in the Northwestern United States, 1982-1997.

Authors:  M A Davis; D D Hancock; T E Besser; D H Rice; J M Gay; C Gay; L Gearhart; R DiGiacomo
Journal:  Emerg Infect Dis       Date:  1999 Nov-Dec       Impact factor: 6.883

View more
  48 in total

1.  Correlation between ceftriaxone resistance of Salmonella enterica serovar Typhimurium and expression of outer membrane proteins OmpW and Ail/OmpX-like protein, which are regulated by BaeR of a two-component system.

Authors:  Wensi S Hu; Pei-Chuan Li; Chao-Yin Cheng
Journal:  Antimicrob Agents Chemother       Date:  2005-09       Impact factor: 5.191

Review 2.  Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria.

Authors:  Laura J V Piddock
Journal:  Clin Microbiol Rev       Date:  2006-04       Impact factor: 26.132

3.  Overexpression of the multidrug efflux operon acrEF by insertional activation with IS1 or IS10 elements in Salmonella enterica serovar typhimurium DT204 acrB mutants selected with fluoroquinolones.

Authors:  Anne Olliver; Michel Vallé; Elisabeth Chaslus-Dancla; Axel Cloeckaert
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

4.  Ciprofloxacin-resistant Salmonella enterica serovar Typhimurium strains are difficult to select in the absence of AcrB and TolC.

Authors:  Vito Ricci; Peter Tzakas; Anthony Buckley; Laura J V Piddock
Journal:  Antimicrob Agents Chemother       Date:  2006-01       Impact factor: 5.191

5.  Promoter discrimination at class I MarA regulon promoters mediated by glutamic acid 89 of the MarA transcriptional activator of Escherichia coli.

Authors:  Robert G Martin; Judah L Rosner
Journal:  J Bacteriol       Date:  2010-11-19       Impact factor: 3.490

6.  Outer membrane protein STM3031 (Ail/OmpX-like protein) plays a key role in the ceftriaxone resistance of Salmonella enterica serovar Typhimurium.

Authors:  Wensi S Hu; Jing-Fang Lin; Ying-Hsiu Lin; Hsin-Yu Chang
Journal:  Antimicrob Agents Chemother       Date:  2009-05-26       Impact factor: 5.191

Review 7.  Xenobiotic efflux in bacteria and fungi: a genomics update.

Authors:  Ravi D Barabote; Jose Thekkiniath; Richard E Strauss; Govindsamy Vediyappan; Joe A Fralick; Michael J San Francisco
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  2011

8.  ICEEc2, a new integrative and conjugative element belonging to the pKLC102/PAGI-2 family, identified in Escherichia coli strain BEN374.

Authors:  David Roche; Maud Fléchard; Nathalie Lallier; Maryline Répérant; Annie Brée; Géraldine Pascal; Catherine Schouler; Pierre Germon
Journal:  J Bacteriol       Date:  2010-07-30       Impact factor: 3.490

9.  The TolC protein of Legionella pneumophila plays a major role in multi-drug resistance and the early steps of host invasion.

Authors:  Mourad Ferhat; Danièle Atlan; Anne Vianney; Jean-Claude Lazzaroni; Patricia Doublet; Christophe Gilbert
Journal:  PLoS One       Date:  2009-11-04       Impact factor: 3.240

10.  Repression of invasion genes and decreased invasion in a high-level fluoroquinolone-resistant Salmonella typhimurium mutant.

Authors:  Anna Fàbrega; Laurence du Merle; Chantal Le Bouguénec; M Teresa Jiménez de Anta; Jordi Vila
Journal:  PLoS One       Date:  2009-11-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.